The lag time from symptoms onset of rheumatoid arthritis to initiation of Methotrexate: data from the Moroccan register of biotherapies
Meryem Eddaoudi(Hôpital El Ayachi), R. Bahiri(Centre Hospitalier Universitaire de Rabat-Salé), R. Abouqal, L. Ichchou(Hôpital El Ayachi), L. Achemlal, R. Niamane(Hôpital Militaire Avicenne), I. Ghozlani(Régie Autonome Multi Services D'Agadir), Bouchra Amine(Hôpital El Ayachi), H. Hassikou, F. Allali(Délégation Paris 5), I. El Binoune(Centre Hospitalier Ibn Sina), I. El Bouchti, Taoufik Harzy(Hôpital El Ayachi), Ihsane Hmamouchi(International University of Rabat), Oufa Mkinsi(Centre Hospitalier Ibn Sina), S. Rostom(Mohammed V University), A. El Maghraoui
Cited by 1
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114